BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30650251)

  • 1. Proteomic Profiling of Acute Promyelocytic Leukemia Identifies Two Protein Signatures Associated with Relapse.
    Hoff FW; Hu CW; Qutub AA; Qiu Y; Hornbaker MJ; Bueso-Ramos C; Abbas HA; Post SM; de Bont ESJM; Kornblau SM
    Proteomics Clin Appl; 2019 Jul; 13(4):e1800133. PubMed ID: 30650251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of protein profile classification model and screening of proteomic signature of acute leukemia.
    Xu Y; Zhuo J; Duan Y; Shi B; Chen X; Zhang X; Xiao L; Lou J; Huang R; Zhang Q; Du X; Li M; Wang D; Shi D
    Int J Clin Exp Pathol; 2014; 7(9):5569-81. PubMed ID: 25337199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CD9
    Ren F; Zhang N; Xu Z; Xu J; Zhang Y; Chen X; Tan Y; Chang J; Wang H
    Int J Lab Hematol; 2019 Apr; 41(2):168-175. PubMed ID: 30315692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of cytokines on early death and coagulopathy in newly diagnosed patients with acute promyelocytic leukemia.
    Zhao S; Ge Y; Li Z; Yang T
    Front Immunol; 2023; 14():1100151. PubMed ID: 37063881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stepwise discriminant function analysis for rapid identification of acute promyelocytic leukemia from acute myeloid leukemia with multiparameter flow cytometry.
    Chen Z; Li Y; Tong Y; Gao Q; Mao X; Zhang W; Xia Z; Fu C
    Int J Hematol; 2016 Mar; 103(3):306-15. PubMed ID: 26759321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunophenotypic features in 143 cases of acute promyelocytic leukemia].
    Sun HM; Qian SX; Wu YJ; Qiao C; Hong M; Fan L; Yang H; Zhang JF; Zhang SJ; Wu HX; Qiu HX; Lu H; Xu W; Sheng RL; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):176-9. PubMed ID: 19236773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel flow cytometric method for enhancing acute promyelocytic leukemia screening by multidimensional dot-plots.
    Kárai B; Habók M; Reményi G; Rejtő L; Ujfalusi A; Kappelmayer J; Hevessy Z
    Ann Hematol; 2019 Jun; 98(6):1413-1420. PubMed ID: 30830246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The comparison of bone marrow kinetics between patients with acute myeloid leukemia and acute promyelocytic leukemia after induction chemotherapy.
    Ciftciler R; Haznedaroglu IC; Ozcebe O; Aksu S; Sayınalp N; Goker H; Demiroglu H; Buyukasık Y
    Immunopharmacol Immunotoxicol; 2020 Feb; 42(1):17-21. PubMed ID: 31744339
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical and laboratory features of patients with CD34(+) acute promyelocytic leukemia].
    Liang JY; Wu DP; Liu YJ; Ma QF; Xue YQ; Zhu MQ; Chen ZX
    Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):196-8. PubMed ID: 19615259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High frequency of acute promyelocytic leukemia among Latinos with acute myeloid leukemia.
    Douer D; Preston-Martin S; Chang E; Nichols PW; Watkins KJ; Levine AM
    Blood; 1996 Jan; 87(1):308-13. PubMed ID: 8547657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute promyelocytic leukemia is a distinct subset of acute myelocytic leukemia with unique clinicopathologic characteristics including longer duration of relapse free survival: experience in 13 cases.
    Lee KH; Kim DH; Lee JS; Suh CW; Kim SW; Kim SB; Lee JH; Doh BS; Chi HS; Lee MS
    J Korean Med Sci; 1994 Dec; 9(6):437-43. PubMed ID: 7786438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative prognostic value of CD34 antigen also if expressed on a small population of acute promyelocytic leukemia cells.
    Breccia M; De Propris MS; Stefanizzi C; Raponi S; Molica M; Colafigli G; Minotti C; Latagliata R; Diverio D; Guarini A; Foà R
    Ann Hematol; 2014 Nov; 93(11):1819-23. PubMed ID: 24912771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional proteomic profiling of AML predicts response and survival.
    Kornblau SM; Tibes R; Qiu YH; Chen W; Kantarjian HM; Andreeff M; Coombes KR; Mills GB
    Blood; 2009 Jan; 113(1):154-64. PubMed ID: 18840713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunophenotype distinction between acute promyelocytic leukaemia and CD15- CD34- HLA-DR- acute myeloid leukaemia with nucleophosmin mutations.
    Ferrari A; Bussaglia E; Úbeda J; Facchini L; Aventin A; Sierra J; Nomdedéu JF
    Hematol Oncol; 2012 Sep; 30(3):109-14. PubMed ID: 21812014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AML M3 and AML M3 variant each have a distinct gene expression signature but also share patterns different from other genetically defined AML subtypes.
    Haferlach T; Kohlmann A; Schnittger S; Dugas M; Hiddemann W; Kern W; Schoch C
    Genes Chromosomes Cancer; 2005 Jun; 43(2):113-27. PubMed ID: 15751046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-DRneg patients without acute promyelocytic leukemia show distinct immunophenotypic, genetic, molecular, and cytomorphologic characteristics compared to acute promyelocytic leukemia.
    Oelschlaegel U; Mohr B; Schaich M; Schäkel U; Kroschinsky F; Illmer T; Ehninger G; Thiede C
    Cytometry B Clin Cytom; 2009 Sep; 76(5):321-7. PubMed ID: 19291801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival and risk factors for mortality in pediatric patients with acute myeloid leukemia in a single reference center in low-middle-income country.
    Lins MM; Mello MJG; Ribeiro RC; De Camargo B; de Fátima Pessoa Militão de Albuquerque M; Thuler LCS
    Ann Hematol; 2019 Jun; 98(6):1403-1411. PubMed ID: 30915498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward Candidate Proteomic Biomarkers in Clinical Monitoring of Acute Promyelocytic Leukemia Treatment with Arsenic Trioxide.
    Cao F; Li X; Yang Y; Fang H; Qu H; Chang N; Ma Q; Cao W; Zhou J; Wang W
    OMICS; 2019 Feb; 23(2):119-130. PubMed ID: 30767729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of PMN elastase in fibrinolytic activity in patients with acute promyelocytic leukemia].
    Soma M; Maeda Y; Kasakura S; Yabe H
    Rinsho Ketsueki; 1990 Sep; 31(9):1445-9. PubMed ID: 2246816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical impact of galectin-3 in newly diagnosed t (15;17)(q22;q21)/PML-RARa acute promyelocytic leukemia treated with all-trans retinoic acid and arsenic trioxide-based regimens.
    Gao N; Wang XX; Sun JR; Yu WZ; Li XZ
    Ann Hematol; 2017 May; 96(5):711-718. PubMed ID: 28238096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.